Structural Heart Masterclass: Aortic Valve | Recorded at the AATS 105th Annual Meeting
This session included the following presentations:
- New Indications for TAVR: Asx and Mod AS Trial Updates - What Floodgates Are Opening?
- Bicuspid TAVR: Do We Need a Trial to Sort This Out?
- Utilization of TAVR in the US: Tipping Point or Tip of the Iceberg?
- Panel Discussion and Case 1: Mod AS with CAD
- Failed TAVR Management
Learning Objectives
Learning Objectives: To understand the current data, learn the latest techniques, understand the direction of the field and innovation, and know the latest clinical trials in the space, through use of didactic lectures, interactive panel discussion, case presentation and discussion, and heart team participation in the following areas:
TAVR: TAVR for AS and AI, Transcatheter AV repair
Mitral Valve Therapies: Transcatheter Mitral Repair and Replacement, MAC Treatment
Tricuspid Valve Therapies: Transcatheter Repair and Replacement
Trends in Transcatheter Utilization: National Registries, Diversity and Access to Care
Complex Valvular Surgery Scenarios:
Elderly patients
Lifetime Management
Multivalvular disease
TAVR Explant
Endocarditis
Comparative Trials between Transcatheter and Surgical Therapies
Transcatheter Aortic Root and Valve Therapies
New Technology for Valve Disease: Preclinical, Early Clinical, and Clinical Trial
Heart Team Scenarios
Challenging Cases
Surgery for failed transcatheter mitral and tricuspid devices.
Purpose (Desired Learning Outcome)
Following this activity, learners will share their intention to apply techniques in diagnosis and therapy for cardiac valve repair in a variety of settings and patient scenarios.
ACCME Accreditation Statement
The American Association for Thoracic Surgery is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA Credit Designation Statement
The American Association for Thoracic Surgery designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit (s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Commercial Support
The AATS received commercial support for the 104th Annual Meeting from:
- Abbott Medtronic
- Merck & Co. Inc.
- Olympus Regeneron
- W.L. Gore & Associates
- Boston Scientific
Available Credit
- 1.00 Participation